Literature DB >> 27364954

Age at Death in Individuals with Intellectual Disabilities.

Maria Arvio1, Tommi Salokivi2, Nina Bjelogrlic-Laakso3.   

Abstract

BACKGROUND: We aimed to ascertain the average age at death (AD) in the intellectual disability population for each gender and compare them to those of the general population during 1970-2012.
METHODS: By analysing medical records, we calculated the ADs of all deceased clients (N = 1236) of two district organizations responsible for intellectual disability services. Statistics Finland's database generated data regarding ADs of all inhabitants who had died after having resided in same district.
RESULTS: During the follow-up, average ADs for the intellectual disability population and general population increased, and simultaneously the AD difference between these populations decreased. In the 2000s, the AD difference between the intellectual disability population and the whole population was 22 years for men (95% CI: -24 to -20) and 30 years for women (95% CI: -33 to -27). In 2000s, the mean AD of those with mild-to-moderate intellectual disability (IQ 50-69) for women and men was 56 (SD17) and 54 (SD18), and those with severe to profound intellectual disability (IQ<50), 44 (SD23) and 43 (SD21).
CONCLUSIONS: Intellectual disability is still a considerable risk factor for early death. Among the intellectual disability population, unlike in general population, the lifespans of women and men are equal.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  age at death; intellectual disability

Mesh:

Year:  2016        PMID: 27364954     DOI: 10.1111/jar.12269

Source DB:  PubMed          Journal:  J Appl Res Intellect Disabil        ISSN: 1360-2322


  6 in total

1.  Signs indicating dementia in Down, Williams and Fragile X syndromes.

Authors:  Oili Sauna-Aho; Nina Bjelogrlic-Laakso; Auli Siren; Maria Arvio
Journal:  Mol Genet Genomic Med       Date:  2018-07-03       Impact factor: 2.183

2.  Cognition in adults with Williams syndrome-A 20-year follow-up study.

Authors:  Oili Sauna-Aho; Nina Bjelogrlic-Laakso; Auli Sirén; Virpi Kangasmäki; Maria Arvio
Journal:  Mol Genet Genomic Med       Date:  2019-04-29       Impact factor: 2.183

3.  All-cause mortality and survival in adults with 22q11.2 deletion syndrome.

Authors:  Lily Van; Tracy Heung; Justin Graffi; Enoch Ng; Sarah Malecki; Spencer Van Mil; Erik Boot; Maria Corral; Eva W C Chow; Kathleen A Hodgkinson; Candice Silversides; Anne S Bassett
Journal:  Genet Med       Date:  2019-04-05       Impact factor: 8.822

4.  Health and care service utilisation and cost over the life-span: a descriptive analysis of population data.

Authors:  Jorid Kalseth; Thomas Halvorsen
Journal:  BMC Health Serv Res       Date:  2020-05-19       Impact factor: 2.655

Review 5.  Opening the door to university health research: recommendations for increasing accessibility for individuals with intellectual disability.

Authors:  Brittany M St John; Emily Hickey; Edward Kastern; Chad Russell; Tina Russell; Ashley Mathy; Brogan Peterson; Don Wigington; Casey Pellien; Allison Caudill; Libby Hladik; Karla K Ausderau
Journal:  Int J Equity Health       Date:  2022-09-10

Review 6.  The reported effects of the COVID-19 pandemic on people with intellectual disability and their carers: a scoping review.

Authors:  Owen Doody; Paul M Keenan
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.